Skip to main navigation Skip to search Skip to main content

A comprehensive IDA and SWATH-DIA Lipidomics and Metabolomics dataset: SARS-CoV-2 case control study

Publications: Contribution to journalArticlePeer Reviewed

Abstract

A significant hurdle in untargeted lipid/metabolomics research lies in the absence of reliable, cross-validated spectral libraries, leading to a considerable portion of LC-MS features being labeled as unknowns. Despite continuous advancement in annotation tools and libraries, it is important to safeguard, publish and share acquired data through public repositories. Embracing this trend of data sharing not only promotes efficient resource utilization but also paves the way for future repurposing and in-depth analysis; ultimately advancing our comprehension of Covid-19 and other diseases. In this work, we generated an extensive MS-dataset of 39 Covid-19 infected patients versus age- and gender-matched 39 healthy controls. We implemented state of the art acquisition techniques including IDA and SWATH-DIA to ensure a thorough insight in the lipidome and metabolome, ensuring a repurposable dataset.

Original languageEnglish
Article number998
Number of pages12
JournalScientific Data
Volume11
Issue number1
DOIs
Publication statusPublished - 12 Sept 2024

Austrian Fields of Science 2012

  • 303009 Nutritional sciences

Keywords

  • Humans
  • COVID-19/metabolism
  • Lipidomics
  • Metabolomics
  • Case-Control Studies
  • SARS-CoV-2
  • Metabolome
  • Mass Spectrometry
  • Female
  • Male
  • Chromatography, Liquid

Fingerprint

Dive into the research topics of 'A comprehensive IDA and SWATH-DIA Lipidomics and Metabolomics dataset: SARS-CoV-2 case control study'. Together they form a unique fingerprint.

Cite this